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Background: Intramural hematoma of the aorta (IMH), a variant of classic aortic dissection, shows very dynamic
process in the early phase. The aim of this study is to evaluate clinical outcomes of patients with acute aortic IMH
from real world registry data.
Methods: We analyzed 165 consecutive patients with acute IMH from five medical centers in Korea. All patients
were divided into two groups; type A (n = 61, 37.0%) and type B (n = 104, 63.0%) according to the Stanford
classification. Clinical outcomes and morphological evolution by CT were analyzed for 2 years.
Results: Most of the patients (77.0% of type A and 99.0% of type B, P < 0.001) were treated medically during their
initial hospitalization. There were no significant differences in in-hospital mortality (4.9% vs. 2.9%, P = 0.671) and
2-year mortality (13.1% vs. 11.5%, P = 0.765) between two groups. During the 2-year follow up period, progression
to aortic dissection (18.0% vs. 6.7%, P = 0.037) and surgical treatment (29.5% vs. 2.9%, P < 0.001) were higher in type A.
For the type A patients, there were no significant difference in in-hospital mortality (7.1% of surgery vs. 4.3% of medical,
P = 0.428) and 2-year mortality (7.1% of surgery vs. 14.9% of medical, P = 0.450) in terms of initial treatment strategy.
Conclusion: For real world practice in Korea, most of IMH patients were treated medically at presentation and showed
favorable outcomes. Thus, even in type A acute IMH, early medical treatment with alternative surgical conversion for
selected, complicated cases would be a favorable treatment option.
Keywords: Intramural hematoma of the aorta, Survival rates, TreatmentBackground
Aortic intramural hematoma (IMH) is an important acute
aortic syndrome that presents symptoms similar to those
of classic aortic dissection. Recent advances in imaging
techniques have significantly improved the diagnosis and
heightened the clinical understanding of IMH, which
accounts for a frequency of 10% to 30% of all acute aortic
syndromes [1-3]. IMH is different from aortic dissection* Correspondence: pjs@med.yu.ac.kr
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unless otherwise stated.due to its absence of continuous direct flow communica-
tion through intimal tear; It shows very dynamic process
in the early phase and the natural history of IMH is not
clearly known yet.
IMH is classified as either involving (type A) or not
involving (type B) the ascending aorta. The site of IMH is
an important parameter to determine prognosis. Patients
with type B IMH, like those with type B aortic dissection,
are usually treated medically [4]. However, management
of patients with type A IMH is controversial. Some reports
have recommended early surgery for patients with type
A IMH because of their poor prognosis with medical
treatment [5-7]. On the other hand, recent studies haved. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Clinical characteristics of the patients, by location






Age, yrs 68 ± 10 67 ± 12 0.521
Sex, male 23 (37.7%) 61 (58.7%) 0.009
Diabetes 4 (6.6%) 7 (6.7%) 0.966
Hypertension 37 (60.7%) 52 (50.0%) 0.185
Dyslipidemia 16 (36.4%) 24 (31.6%) 0.688
Current smoking 20 (32.8%) 30 (28.8%) 0.595
Time from onset to admission (hrs) 10.6 ± 16.2 7.9 ± 11.3 0.251
Initial symptoms 0.372
Chest pain 31 (50.8%) 58 (55.8%) 0.538
Abdominal pain 11 (18.0%) 21 (20.2%) 0.735
Back pain 10 (16.4%) 19 (18.3%) 0.760
Loss of consciousness 2 (3.3%) 3 (2.9%) 1.000
Dyspnea 4 (6.6%) 1 (1.0%) 0.159
Others 3 (4.9%) 2 (1.2%) 0.360
Hemodynamic findings
Systolic BP, mmHg 138 ± 36 150 ± 36 0.042
Diastolic BP, mmHg 84 ± 21 86 ± 19 0.522
Heart rate, BPM 77 ± 18 77 ± 23 0.997
Laboratory findings
Total cholesterol (mg/dL) 185 ± 53 180 ± 46 0.550
C-reactive protein (mg/dL) 3.2 ± 4.3 4.7 ± 8.3 0.236
Creatinine (mg/dL) 1.20 ± 1.50 0.97 ± 0.34 0.279
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type A IMH cases [8,9]. Therefore, we retrospectively
analyzed imaging studies, treatment strategies and clin-




From January 2000 through December 2010, a total of
165 patients with acute IMH were admitted to five med-
ical centers. IMH was defined as a circular or crescent
shape, extensive aortic wall hematoma with no evidence of
intimal flap or false lumen noted by contrast computed
tomographic (CT) scan. The patients were divided into
two groups according to the aortic segment afflicted with
IMH, whether it was on the ascending thoracic aorta and/
or aortic arch (type A, n = 61) or the descending thoracic
aorta (type B, n = 104). Clinical features, hospital mortality,
and long-term survivals were compared between patients
with type A and type B IMH for 2 years.
Data collection and analysis
Chart review was performed, and data were collected with
a standardized format that included information on patient
demographics, medical history, clinical presentation, phys-
ical findings, results of imaging studies, details of medical
and surgical treatment, and outcome. Follow-up data were
collected by direct telephone interviews and detailed review
of all medical records. The cause and date of any death
were confirmed by information gathered from the National
Population Registry of the Korean National Statistical
Office, together with a review of all available clinical records
at the time of death. This retrospective study was approved
by the Institutional review board of Yeungnam University
(IRB No. YUH-13-0362-B3). The need for informed con-
sent was waived by the board.
Statistical analysis
Categorical variables are described as number and percent
and compared with the chi-squared test, or Fisher exact
test as appropriate. Continuous variables are described as
mean ± SD. Survival analysis was performed by Kaplan-
Meier analysis, and differences in survival between the
groups were examined with the log-rank test. To deter-
mined predictors for progression of ascending IMH and
mortality throughout follow-up period, Cox proportional
hazards model was used to estimate the risk of the poten-
tial variables. P value < 0.05 (two-sided) was considered
statistically significant. Data analyses were performed with
SPSS software (version 18.0; SPSS, Inc, Chicago, Ill).
Results
Table 1 summarizes the clinical features of both groups.
Mean age (68 ± 10 vs. 67 ± 12, P = 0.521), the prevalenceof diabetes (6.6% vs. 6.7%, P = 0.966), hypertension
(60.7% vs. 50.0%. P = 0.185), dyslipidemia (36.4% vs. 31.6%,
P = 0.688), current smoking status (32.8% vs. 28.8%,
P = 0.595) and time from onset to admission (10.6 ± 16.2 vs.
7.9 ± 11.3, P = 0.251) did not show any difference between
the two groups. Male gender was more frequently observed
in the type B group (37.7% vs. 58.7%, P = 0.009). Chest
pain was the most prevalent symptom in both groups.
Abdominal pain and back pain followed that. Initial
systolic blood pressure was higher in the type B group
(138 ± 36 vs. 150 ± 36, P = 0.042). Diastolic blood pressure
(84 ± 21 vs. 86 ± 19, P = 0.522) and heart rate (77 ± 18 vs.
77 ± 23, P = 0.997) were no statistically significantly differ-
ent between the two groups. The laboratory findings were
also similar in the two groups.
Selected treatment modalities and clinical outcomes
are summarized in Figure 1. In the type A group, 23%
(14/61) underwent emergent surgery, and medical treat-
ment was selected for the remaining 47 patients. Among
patients who were treated medically at initial presentation,
3 patients underwent surgery during the hospitalization
because of the development of hemopericardium, aggrava-
tion of pleural effusion and dye leakage detected from
Figure 1 Diagram of enrolled patients and clinical outcomes. MTX, medical treatment; STX, surgical treatment.
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surgery because of the development of aortic dissection.
In the type B group, one patient underwent emergent
surgery because suspicious penetrating ulcer was seen
in CT. Additional 2 patients underwent timely surgery
after enlarged aortic diameter (up to 63 mm) and extrava-
sation of dye were seen from follow up CT examination.
Most patients with type B (101/104, 97.1%) IMH received
medical treatment only. A total of 21 patients who were
underwent surgery during 2 years, 20 cases had aorta graft
replacement and 1case had hybrid EVAR (endovascular
aneurysm repair).
The results of CT were demonstrated in Table 2 accord-
ing to the time of examinations. Initial, in-hospital follow
up, outpatient department follow up CT results were seen.
With the use of computerized planimetry, measurements
were taken on the basis of the accompanying calibrated
scales in the contrast-enhanced CT images. Maximal
aortic diameter and maximal hematoma thickness were
measured at the level of pulmonary artery bifurcation
(Figure 2). Maximal ascending aortic diameter in initial
CT images was significantly greater in the type A group
(47.8 ± 8.2 mm vs. 42.1 ± 5.7 mm, P < 0.001). Maximal
descending aortic diameter was greater in the type B group,
but there was no significant difference (37.7 ± 7.4 mm vs.
40.0 ± 8.1 mm, P = 0.084). Maximal descending hematoma
thickness in type A was 10.8 ± 6.8 mm and maximal de-
scending hematoma thickness in type B was 11.6 ± 5.1 mm.
Pericardial effusion was common in the type A group
(32.8% vs. 3.9%, P < 0.001). In-hospital follow up CT was
performed in 78.8% of patients (mean duration 10 ± 7 days).
Among them, 59.6% of type A and 41.0% of type B patientsshowed a decreasing trend of hematoma thickness. There
were no significant differences of hematoma thickness
(less than 2 mm) compared to initial CT in the 34.0%
of type A and 50.0% of type B patients. Progression to
aortic dissection was common in type A patients (12.8%
vs. 3.6%, P = 0.069). Outpatient department follow up CT
was performed only in 58.2%. However, information from
the National Population Registry of the Korean National
Statistical Office and direct telephone interview confirmed
that other patients were asymptomatic and in stable
condition except the person who died. To determine
the independent predictors for progression of type A IMH
throughout the follow-up period, Cox regression analysis
was performed. There was no significant predictor of the
progression of IMH. However, aortic hematoma thickness
greater than 10 mm was associated with increased mortal-
ity (odds ratio, 9.23; 95% Confidence interval (CI), 1.30 to
65.4; P = 0.026) (Table 3).
Table 4 shows treatment strategy and clinical outcomes
according to location of IMH. Patients receiving emergent
surgery had been hospitalized longer than those receiv-
ing medical therapy in both type A (29 ± 14 vs. 16 ± 8,
P = 0.004) and type B (26 vs. 17 ± 13, P = 0.492) groups.
During the 2-year follow up period, progression to aortic
dissection (18.0% vs. 6.7%, P = 0.037) and surgical treat-
ment (29.5% vs. 2.9%, P < 0.001) were common in type A.
However, there were no significant difference in-hospital
mortality (4.9% vs. 2.9%, P = 0.671) and 2-year mortality
(13.1% vs. 11.5%, P = 0.765) between type A and B. In the
type A patients, there were no significant difference in
in-hospital mortality (7.1% of surgery vs. 4.3% of medical,
P = 0.428) and 2-year mortality (7.1% of surgery vs. 14.9%
Table 2 The results of CT examinations
Type A (n = 61) Type B (n = 104) P value
Initial computed tomography
Maximal ascending aortic diameter, mm 47.8 ± 8.2 42.1 ± 5.7 < 0.001
Maximal descending aortic diameter, mm 37.7 ± 7.4 40.0 ± 8.1 0.084
Maximal ascending hematoma thickness, mm 10.8 ± 6.8 - < 0.001
Maximal descending hematoma thickness, mm 9.9 ± 5.0 11.6 ± 5.1 0.042
Pleural effusion 14 (23.0%) 22 (21.4%) 0.812
Pericardial effusion 20 (32.8%) 4 (3.9%) < 0.001
In-hospital follow up CT
Follow-up CT duration, days 10 ± 7 9 ± 7 0.483
Follow-up CT study 47 (77.0%) 84 (80.8%) 0.568
Decreased hematoma 28 (59.6%) 34 (41.0%) 0.041
Increased hematoma 3 (6.4%) 7 (8.4%) 0.480
Progression to aortic dissection 6 (12.8%) 3 (3.6%) 0.069
No change* 16 (34.0%) 42 (50.0%) 0.068
Outpatient Department follow up CT
Follow-up CT duration, days 452 ± 724 318 ± 453 0.267
Follow-up CT study 38 (62.3%) 58 (55.8%) 0.412
Decreased hematoma 29 (78.4%) 48 (82.8%) 0.401
Increased hematoma 3 (7.9%) 4 (6.9%) 1.000
Progression to aortic dissection 5 (13.2%) 5 (8.6%) 0.510
No change* 6 (15.8%) 6 (10.3%) 0.430
*No change; Change of hematoma thickness is less than 2 mm compared to initial CT.
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(Figure 3).
Discussion
Aortic IMH, known as a variant form of aortic dissection,
is characterized by the absence of intimal tear and direct
flow communication between true and false lumen. ItFigure 2 Measurement methods of intramural hematoma of
the aorta. Maximal aortic diameter (A) and maximal hematoma
thickness (B) were measured at the level of pulmonary artery bifurcation.
AD, Maximal ascending aortic diameter; AH, Maximal ascending
hematoma thickness; DD, Maximal descending aortic diameter; DH,
Maximal descending hematoma thickness; PA, Pulmonary artery.results from spontaneous rupture of aortic vasa vasorum
or penetrating atherosclerotic ulcer [10-12]. Recent
advances in noninvasive imaging such as computed
tomography (CT), magnetic resonance (MR) imaging,
and transesophageal echocardiography (TEE) are used to
identify a variant of aortic dissection and have furtherTable 3 Predictors of 2-year mortality by Cox regression
analysis
Odds ratio 95% confidence
interval
P value
Age > 70 years 1.64 0.23 - 11.78 0.623
Diabetes 0 0 0.987
Hypertension 2.81 0.42 - 18.61 0.285
Dyslipidemia 0.26 0.02 - 2.99 0.278
Time from onset to
admission > 24 hrs
1.67 0.25 - 11.09 0.600
Initial systolic BP < 90 mmHg 3.00 0.04 - 202.96 0.609
Pleural effusion at CT 0.38 0.02 - 0.68 0.509
Pericardial effusion at CT 3.51 0.18 - 67.84 0.405
Maximal ascending aortic
diameter > 55 mm
1.43 0.17 - 11.69 0.740
Maximal ascending hematoma
thickness > 10 mm
9.23 1.30 - 65.4 0.026
Table 4 Treatment strategy and clinical outcomes according to location of aortic intramural hematoma
Type A (n = 61) Type B (n = 104) P value
Admission duration (days) 19 ± 11 17 ± 13 0.535
Emergency surgery (within 24 hrs) 29 ± 14 26 0.855
Medical therapy and timely surgery 16 ± 8 17 ± 13 0.404
In-hospital mortality 3/61 (4.9%) 3 /104 (2.9%) 0.671
Emergency surgery (within 24 hrs) 1/14 (7.1%) 0/1 (0%) 1.000
Medical therapy and timely surgery 2/47 (4.3%) 3/103 (2.9%) 0.649
2-year mortality 8/61 (13.1%) 12/104 (11.5%) 0.765
Emergency surgery (within 24 hrs) 1/14 (7.1%) 0/1 (0%) 1.000
Medical therapy and timely surgery 7/47 (14.9%) 12/103 (11.7%) 0.580
Progression to aortic dissection for 2 years 11 (18.0%) 7 (6.7%) 0.037
Surgical treatment for 2 years 18 (29.5%) 3 (2.9%) < 0.001
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aortic syndrome. Among them, CT is widely used as the
imaging modality of first choice for the assessment of
thoracic aortic disease and can be used even in clinically
unstable patients. Moreover, various diameters of the
aorta can be measured easily in serial CT images such
as aortic diameter and aortic wall thickness [1,13-15].
There are several studies that propose these parameters as
a prognostic factor. Maximum aortic diameter ≥ 50 mm,
hematoma thickness ≥ 11 mm are supposed to predict
adverse clinical outcome [16,17]. Our study also showed
that patients with larger hematoma thickness (≥10 mm) at
initial CT were considered as a high risk group. Perhaps
this is because larger hematoma thickness might represent
a larger blood accumulation in the aortic wall, which
could increase the risk of development of aortic dissection
or perivascular leakage.
The management of IMH of the aorta remains contro-
versial. Existing studies have suggested that different
therapeutic strategy based on the affected area be used
as the site of IMH is an important parameter to determineFigure 3 Survival rates of type A acute intramural hematoma accordi
were 92.9% who received emergency surgery vs. 95.7% who received med
During 2-year follow up, Survival rates were 92.9% who received emergenc
in selected patients (P = 0.450).prognosis. Usually patients with distal IMH involving the
descending aorta (Stanford type B) treated medically and
their favorable prognosis is demonstrated in many studies.
Kaji et al. reported long-term clinical course of patients
with type B IMH. In their study, treated initially with med-
ical therapy, type B IMH shows lower in-hospital mortality
(0% vs. 14%, P = 0.006) and higher 5-year survival rates
(97% vs. 79%, P = 0.009) compared with type B aortic
dissection [18]. Song et al. reported that absence of per-
sistent flow communication in the false lumen resulted
in a favorable remodeling process in IMH affecting distal
descending aorta [19]. It has been reported that even type
B IMH could progress to overt dissection or aortic rupture
[20]. Medical therapy is generally accepted in initial
management of type B IMH.
However, management of patients with type A IMH is
controversial. Some studies reported that medically treated
type A IMH patients showed worse prognosis than sur-
gically treated patients. Because short term prognosis is
serious in IMH involving the ascending aorta owing to
frequent progression to aortic rupture, dissection orng to the initial treatment strategy. (A) In-hospital survival rates
ical therapy and timely surgery in selected patients (P = 0.428). (B)
y surgery vs. 85.1% who received medical therapy and timely surgery
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come in type A patients [7,21]. However, the progression
of type A IMH appears to be more benign than that of
aortic dissection and studies from Asian countries reported
low mortality rates in medically treated proximal IMH.
Song et al. reported that among medically treated type A
IMH patients, 67% showed disappearance of hematoma
and 78% survived during 3-year follow-up [9,22]. In another
study of type A patients treated initially with supportive
medical therapy, in-hospital mortality rate was significantly
lower (7% vs. 34%, P = 0.004) and 5-year survival rates was
significantly higher (90% vs. 62%, P = 0.004) than aortic
dissection group [23]. Another recent study conducted
for North American and European showed that the
majority of type A IMH patients (84.4%) received surgical
treatment. Even though there was no direct comparison
between surgically treated and medically treated type A
IMH, the mortality in medically treated group (40.0%) was
much higher than that of surgically treated group (24.1%)
[24]. Although the exact cause is unknown, IMH is diag-
nosed much more frequently and has better outcomes in
Japan/Korea than North America/Europe. It is possibly
due to the heightened awareness of the IMH diagnosis
and detect more benign variant of IMH. In addition,
genetic, dietary, or environmental factors may influence
geographic variation [25].
Previous studies have shown that medical treatment
alone was not enough to manage all type A IMH patients.
Patients with recurrent pain, progression to overt type A
dissection, or progressive aortic dilatation during medical
follow-up should converted to surgery [26]. To monitor
the morphological changes and development of delayed
vascular complications such as that, regular follow-up
imaging will be essential [27]. In addition, recent technical
improvements in surgery for acute aortic syndrome have
resulted in reduced operative mortality. Moreover, delayed
surgery did not increase mortality [8,28]. Thus, supportive
medical treatment with frequent follow-up imaging
studies and timed surgical repair can be a rational thera-
peutic strategy in management of type A IMH. In this
study, we analyzed 165 Asian patients with IMH, and this
is one of the largest studies of IMH to date. There were
also no significant difference in in-hospital mortality and
2-year mortality according to initial treatment strategy.
Based on our data, medical therapy with or without timely
operation resulted in favorable long-term results similar
to other studies from Asia.
There are several limitations in our study. First, it was
a retrospective analysis of data and not a randomized
study. There were no definite criteria for surgical therapy.
Second, the rates of CT follow-up were low and this may
underestimate progression of IMH. Third, there were a
relatively small number of patients who developed aortic
dissections or who died. Thus, we did not have adequatepower to identify risk factors of these outcomes. Fourth,
we did not take into account the variations of normal
aortic dimensions related to age.
Conclusions
For real world practice in Korea, most of IMH patients
were treated medically at presentation and showed favor-
able outcomes. Thus, even in type A acute IMH, early
medical treatment with alternative surgical conversion
for selected, complicated cases would be a favorable treat-
ment option. Moreover it can also reduce medical costs
through the shorter hospitalization period and the reduc-
tion of operation charge. Longer follow-up observation of
more patients is needed to assess the real impact of the
initial hematoma thickness on the prognosis of IMH and
timing of surgical intervention.
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